Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220

GH Secretagogues & Growth Factors

GHRH receptor analogues, selective ghrelin/GHS-R1a mimetics, somatotropic proteins, and myostatin/IGF-1 pathway research reagents.

≥99.0%
ACE-031 1 mg — ≥99.0% Research Vial
ACE-031
1 mg In stock
CAS 1169766-01-1
MW: ~79.0 kDa (homodimer)
€75
≥99.0%
CJC-1295 5 mg — ≥99.0% Research Vial
CJC-1295
5 mg In stock
CAS 863288-34-0 (with DAC)
MW: 3647.28 g/mol
€48
≥99.0%
CJC-1295 + Ipamorelin 5mg + 5mg — ≥99.0% Research Vial
CJC-1295 + Ipamorelin
5mg + 5mg In stock
CAS 863288-34-0 / 170851-70-4
MW: 3367.97 g/mol & 711.86 g/mol
€62
≥99.0%
Follistatin 1 mg — ≥99.0% Research Vial
Follistatin
1 mg In stock
CAS 117628-82-7
MW: ~34.8 kDa (non-glycosylated core)
€82
≥99.0%
GHRP-2 5 mg — ≥99.0% Research Vial
GHRP-2
5 mg In stock
CAS 158861-67-7
MW: 817.97 g/mol
€32
≥99.0%
GHRP-6 5 mg — ≥99.0% Research Vial
GHRP-6
5 mg In stock
CAS 87616-84-0
MW: 873.01 g/mol
€32
≥99.0%
Hexarelin 5 mg — ≥99.0% Research Vial
Hexarelin
5 mg In stock
CAS 140703-51-1
MW: 887.04 g/mol
€36
≥99.0%
HGH 10 IU (3.33 mg) — ≥99.0% Research Vial
HGH
10 IU (3.33 mg) In stock
CAS 12629-01-5
MW: 22,124 Da (191-aa polypeptide)
€68
≥99.0%
IGF-1 LR3 1 mg — ≥99.0% Research Vial
IGF-1 LR3
1 mg In stock
CAS 946870-92-4
MW: 9111.50 g/mol
€68
≥99.2%
Ipamorelin 5 mg — ≥99.2% Research Vial
Ipamorelin
5 mg In stock
CAS 170851-70-4
MW: 711.85 g/mol
€38
≥99.0%
PEG-MGF 2 mg — ≥99.0% Research Vial
PEG-MGF
2 mg In stock
CAS 108174-48-7 (MGF core, PEGylated)
MW: ~22.9 kDa (2868 Da peptide + 20 kDa mPEG)
€46
≥99.0%
Sermorelin 5 mg — ≥99.0% Research Vial
Sermorelin
5 mg In stock
CAS 86168-78-7
MW: 3357.88 g/mol
€42
≥99.0%
Tesamorelin 5 mg — ≥99.0% Research Vial
Tesamorelin
5 mg In stock
CAS 218949-48-5
MW: 5135.77 g/mol
€58
Analytical Pathway Scope

Scientific Overview: GH Secretagogues & Growth Factors

Somatotropic axis research requires strict structural distinction between Class B GHRH receptor agonists (Sermorelin, CJC-1295 No DAC, CJC-1295 with DAC, Tesamorelin) and Class A GHS-R1a ghrelin mimetics (Ipamorelin, GHRP-2, GHRP-6, Hexarelin), as well as downstream anabolic signaling proteins (IGF-1 LR3, Follistatin-344, PEG-MGF, ACE-031, rhGH).

Short synthetic secretagogues undergo RP-HPLC and ESI-MS release verification, while recombinant folded proteins (rhGH 191-aa, IGF-1 LR3, Follistatin, and ACE-031) are evaluated via SEC-HPLC and SDS-PAGE to confirm native monomeric integrity.

Primary Research Mechanisms

  • Pituitary GHRH-R cAMP/PKA activation
  • Selective GHS-R1a PLC/Ca²⁺ signaling
  • IGF-1R tyrosine kinase & PI3K/Akt signaling
  • ActRIIB / myostatin ligand sequestration

Related GH Secretagogues & Growth Factors Monographs

GH Secretagogues & Growth Factors — Technical FAQ

What is the structural difference between CJC-1295 No DAC and CJC-1295 with DAC?

CJC-1295 No DAC (Mod GRF 1-29) is a 29-amino acid tetrasubstituted GHRH analogue resistant to DPP-4 cleavage (~30 min half-life). CJC-1295 with DAC adds a C-terminal lysine-MPA linker that covalently binds serum albumin Cys34, extending half-life to 6–8 days.

Why does IGF-1 LR3 require dilute acetic acid for initial reconstitution?

IGF-1 LR3 is an 83-amino acid polypeptide that exhibits low solubility and rapid adsorption in neutral water. Pre-dissolving in sterile 0.6% (10 mM) acetic acid before diluting with buffered carrier solution preserves recovery and biological activity.

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog